Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NF-kappaB and cytokines.

Dagmar Kulms1, Thomas Schwarz

  • 1Department of Cell Biology and Immunology, University of Stuttgart, D-70569 Stuttgart, Germany.

Vitamins and Hormones
|October 10, 2006
PubMed
Summary

Nuclear factor-kappaB (NF-kappaB) is a key regulator in physiological and pathological processes, influencing cell death and homeostasis. Targeting NF-kappaB for cancer therapy requires understanding its complex interactions with cytokines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The kinetochore proteins Ndc80 and Dsn1 are required for survival of postmitotic neurons.

bioRxiv : the preprint server for biology·2026
Same author

Loss of SARM1 Improves Phenotypes in a Mouse Model of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

Neurology. Genetics·2026
Same author

An unusual granulomatous tinea due to <i>Nannizzia incurvata</i> in Germany without evidence of an acquisition from outside Europe and reduced itraconazole susceptibility.

Medical mycology case reports·2026
Same author

Bullous lichen sclerosus: A rare differential diagnosis of a blistering genital dermatosis.

JAAD case reports·2025
Same author

SARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy.

The Journal of clinical investigation·2025
Same author

Pharmacological targeting of caspase-8/c-FLIP<sub>L</sub> heterodimer enhances complex II assembly and elimination of pancreatic cancer cells.

Communications biology·2025

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Cytokines are soluble mediators involved in physiological and pathological processes.
  • Nuclear factor-kappaB (NF-kappaB) is a transcription factor mediating cytokine release and biological activities.
  • NF-kappaB plays crucial roles in tissue development, homeostasis, and apoptosis of normal and malignant cells.

Purpose of the Study:

  • To highlight the significance of NF-kappaB as a therapeutic target in anticancer and anti-inflammatory strategies.
  • To emphasize the intricate relationship between NF-kappaB and cytokines.
  • To underscore the importance of considering cytokine-mediated alterations of NF-kappaB activity in therapeutic development.

Main Methods:

  • Review of existing literature on NF-kappaB and cytokine signaling pathways.
  • Analysis of the role of NF-kappaB in cellular processes, including apoptosis and homeostasis.
  • Examination of the cross-talk between cytokines and NF-kappaB activity.

Main Results:

  • NF-kappaB is a central mediator in numerous biological processes.
  • NF-kappaB is a promising target for anti-cancer and anti-inflammatory therapies.
  • Cytokines can alter NF-kappaB activity, indicating a complex regulatory network.

Conclusions:

  • Targeting NF-kappaB is a viable strategy for treating cancer and inflammatory diseases.
  • The interplay between NF-kappaB and cytokines must be considered for effective therapeutic strategies.
  • Understanding this cross-talk is essential for developing successful NF-kappaB-targeted therapies.

Related Experiment Videos